Methotrexate Sodium
Who holds supplier records for Methotrexate Sodium? 5 organisations hold a current record for Methotrexate Sodium: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3), Germany (1) and Finland (1).
Most records are filed under another form of this substance: Methotrexate (9 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Methotrexate Sodium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/methotrexate-sodium
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Methotrexate Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 36277 · latest filing Sept 2021
- EXCELLA GMBH AND CO KGGermany Company GMP cert on recordActive DMF 12472 · latest filing Apr 1997
- FERMION OYFinland Company GMP cert on recordActive DMF 23532 · latest filing Jan 2010
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 42627 · latest filing Nov 2025
- SHILPA PHARMA LIFESCIENCES LTDIndiaActive DMF 42795 · latest filing Oct 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Methotrexate Sodium are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- HEINRICH MACK NACHFOLGERInactive DMF 10863 · filed Apr 1994
- LACHEMA BRNOInactive DMF 9526 · filed Jan 1992
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Methotrexate sodium is a folate analog metabolic inhibitor that exerts its antineoplastic and immunosuppressive properties by inhibiting the enzyme dihydrofolate reductase, interfering with DNA synthesis, repair, and cellular replication. It is used in the treatment of various types of cancer and autoimmune diseases such as rheumatoid arthritis.
Chemical identity
- IUPAC name
- disodium;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioate
- Canonical SMILES
- CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].[Na+].[Na+]
- InChIKey
- FBOZXECLQNJBKD-ZCXUNETKSA-M
- Synonyms
- MTX
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Folate Analog Metabolic Inhibitor
- Mechanism of action
- Folic Acid Metabolism Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Methotrexate Sodium?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Methotrexate Sodium: Alembic Pharmaceuticals Limited (India), EXCELLA GMBH AND CO KG (Germany), FERMION OY (Finland), MSN Laboratories Private Limited (India) and SHILPA PHARMA LIFESCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Methotrexate Sodium Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 36277), EXCELLA GMBH AND CO KG (DMF 12472), FERMION OY (DMF 23532), MSN Laboratories Private Limited (DMF 42627) and SHILPA PHARMA LIFESCIENCES LTD (DMF 42795). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Methotrexate Sodium records mean?
2 organisations have only inactive Type II DMFs for Methotrexate Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Methotrexate Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Methotrexate Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.